MedPath

Strategies of Therapy With the Exoskeleton Robot ARMin

Not Applicable
Completed
Conditions
Stroke
Interventions
Device: ARMin
Other: Occupational Therapy
Registration Number
NCT03100422
Lead Sponsor
Swiss Federal Institute of Technology
Brief Summary

Neurological patients (e.g., after stroke) need long-term neurorehabilitation therapy of the arm with often limited, unsatisfactory outcome. Robots became a promising supplement or even alternative for neurorehabilitation training.

Detailed Description

The exoskeleton robot ARMin was further developed and software components adapted accordingly to offer a unique intensified and patient-tailored robot-aided training of the arm. The goal is to enhance treatment efficacy to an extent that the improvement in motor function is meaningful for the individual patient. The study objective is to compare ARMin therapy and a form of conventional occupational therapy that involves both arms regarding change in motor function.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
    • Aged ≥18 years
  • Ischemic cerebral vascular accident (CVA, stroke) in the sub-acute phase (one to twelve weeks post-stroke) as verified by brain imaging (CT or MRI)
  • Inpatient at Rehaklinik Zihlschlacht, Switzerland
  • Decreased arm motor function in one arm with a FMA of 8 to 20 points (out of 66)
  • No excessive spasticity of the affected arm (modified Ashworth Scale mAS ≤3) as assessed by the physician
  • No serious medical or psychiatric disorder as assessed by the physician
  • No serious orthopaedic, rheumatologic or other disease restricting movements of the paretic arm as assessed by the physician
  • No clinically significant shoulder subluxation (palpation <2 fingers) as assessed by the physician
  • No skin ulcerations at the paretic arm as assessed by the physician
  • Ability to communicate effectively with the examiner such that the validity of the patient's data could not be compromised as assessed by the physician
  • No history of cyber sickness (e.g., nausea when looking at a screen or playing computer games) as assessed by the physician
  • No pacemaker or other implanted electric device as verified by patient record
  • Bodyweight <120 kg
  • No serious cognitive defects or aphasia preventing effective use of ARMin as assessed by the physician
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ARMinARMinTherapy with the arm therapy robot ARMin
Arm+ occupational therapyOccupational Therapya form of conventional occupational therapy that involves both arms
Primary Outcome Measures
NameTimeMethod
Fugl Meyer Assessment, upper extremity motor functionfrom baseline to day 3 post-training

impairment based clinical test

Secondary Outcome Measures
NameTimeMethod
Motor Activity Logfrom baseline to day 3 post-training

questionnaire

handheld dynamometerfrom baseline to day 3 post-training

isometric strength

ARMin assessment timefrom baseline to day 3 post-training

time

ARMin assessment torquesfrom baseline to day 3 post-training

torques

Intrinsic Motivation Inventoryfrom baseline to day 3 post-training

questionnaire

ARMin assessment positionsfrom baseline to day 3 post-training

positions

Trial Locations

Locations (1)

Labor für Sensomotorische Systeme, ETH Zürich, Balgrist Campus

🇨🇭

Zürich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath